[Yung Shin] Announcement of the Approval of Non-Compete Restriction Removal for Directors at the 2026 Annual General Meeting

1. Date of Shareholders' Meeting Resolution: 2026/05/27 2. Names and titles of directors permitted to engage in competitive activities: (1) Director: Li Ling-jin (2) Director: Representative of Bio-Tech Holdings Co., Ltd.: Li Fang-yu (3) Director: Representative of Yung-Chuan Investment Co., Ltd.: Li Fang-chuan 3. Items permitted: Investing in or managing companies with the same or similar business scope as the company, and serving as a director or manager. 4. Duration: During the term of office as a director of the company. 5. Resolution details (pursuant to Article 209 of the Company Act): Passed as proposed after a vote by shareholders representing at least two-thirds of the total issued shares. 6. Directors involved in competitive activities in mainland China: Director: Representative of Yung-Chuan Investment Co., Ltd.: Li Fang-chuan 7. Name and position in the mainland Chinese entity: Director of De-Zhen Pharmaceutical (Jiangsu) Co., Ltd. 8. Address of the mainland Chinese entity: No. 191, Jinyang West Road, Lujia Town, Kunshan City, Jiangsu Province. 9. Business scope of the mainland Chinese entity: Pharmaceutical wholesale, pharmaceutical retail, and food sales. 10. Impact on the company's financial and business operations: No material impact. 11. Investment amount and shareholding ratio in the mainland Chinese entity: None. 12. Other matters: None.